Research category

Annals of clinical and translational neurology. 2019 Jan 8;6(2):392-6. doi: 10.1002/acn3.712

Comparison of multiple sclerosis patients with and without oligoclonal IgG bands in South China. Lu T, Zhao L, Sun X, Au C, Huang Y, Yang Y, Bao J, Wu A, Kermode AG, Qiu W, Lau AY. J Clin Neurosci. 2019 Aug;66:51-55. doi: 10.1016/j.jocn.2019.05.025.

Lu T, Zhao L, Sun X, Au C, Huang Y, Yang Y, Bao J, Wu A, Kermode AG, Qiu W, Lau AY. J. Comparison of multiple sclerosis patients with and without oligoclonal IgG bands in South China. Clin Neurosci. 2019 Aug;66:51-55. doi: 10.1016/j.jocn.2019.05.025.

Joshi S, Kermode AG. Harding’s disease: an important MS mimic. BMJ Case Rep. 2019 Mar 31;12(3). pii: e228337. doi: 10.1136/bcr-2018-228337.

The global burden of neurological disorders. Carroll WM. Lancet Neurol. 2019 May;18(5):418- 419. doi: 10.1016/S1474-4422(19)30029-8.

Short-term changes in frequencies of circulating leukocytes associated with narrowband UVB phototherapy in people with clinically isolated syndrome. Stephanie Trend, Anderson P. Jones, Lilian Cha, Matthew N. Cooper, Sian Geldenhuys, Marzena J. Fabis-Pedrini, William M. Carroll, Judith M. Cole, David R. Booth, Robyn M. Lucas, Martyn A. French, Scott N. Byrne, Allan G. Kermode & Prue H. Hart. Scientific Reports volume 9, Article number: 7980 (2019).

Short-term changes in frequencies of circulating leukocytes associated with narrowband UVB phototherapy in people with clinically isolated syndrome. Trend S, Jones AP, Cha L, Cooper MN, Geldenhuys S, Fabis-Pedrini MJ, Carroll WM, Cole JM, Booth DR, Lucas RM, French MA, Byrne SN, Kermode AG, Hart PH. Sci Rep. 2019 May 28;9(1):7980. doi: 10.1038/s41598-019-44488-6.

Brown JWL, Coles A, Horakova D, Havrdova E, Izquierdo G, Prat A, Girard M, Duquette P, Trojano M, Lugaresi A, Bergamaschi R, Grammond P, Alroughani R, Hupperts R, McCombe P, Van Pesch V, Sola P, Ferraro D, Grand’Maison F, Terzi M, Lechner-Scott J, Flechter S, Slee M, Shaygannejad V, Pucci E, Granella F, Jokubaitis V, Willis M, Rice C, Scolding N, Wilkins A, Pearson OR, Ziemssen T, Hutchinson M, Harding K, Jones J, McGuigan C, Butzkueven H, Kalincik T, Robertson N; MSBase Study Group. (Kermode A, is a member of MSBase). Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis. JAMA. 2019 Jan 15;321(2):175-187. doi: 10.1001/jama.2018.20588.

Zhong X, Chang Y, Tan S, Wang J, Sun X, Wu A, Peng L, Lau AY, Kermode AG, Qiu W. Relapsing optic neuritis and meningoencephalitis in a child: case report of delayed diagnosis of MOG-IgG syndrome. BMC Neurol. 2019 May 9;19(1):94. doi: 10.1186/s12883-019-1324-4.

Fang L, Kang X, Wang Z, Wang S, Wang J, Zhou Y, Chen C, Sun X, Yan Y, Kermode AG, Peng L, Qiu W. MOG-IgG contributes to oligodendrocytopathy in the presence of complement distinct from astrocytopathy induced by AQP4-IgG. Neurosci. Bull. (2019). doi.org/10.1007/s12264-019-00375-8.